Evert J. Van Limbergen

p16INK4a Impairs Homologous Recombination–Mediated DNA Repair in Human Papillomavirus–Positive Head and Neck Tumors

Rüveyda Dok, Peter Kalev, Evert J. Van Limbergen et al. · Cancer Research · 2014 · 118 citations · Full text

The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses

Nicolle H. Rekers, Verónica Olivo Pimentel, Ala Yaromina et al. · OncoImmunology · 2017 · 49 citations · Full text

Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making

Anshu Ankolekar, Ben Vanneste, Esther Bloemen‐van Gurp et al. · BMC Medical Informatics and Decision Making · 2019 · 49 citations · Full text

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

R. Lieverse, Evert J. Van Limbergen, Cary Oberije et al. · BMC Cancer · 2020 · 46 citations · Full text

Online pretreatment verification of high-dose rate brachytherapy using an imaging panel

Gabriel Paiva Fonseca, Mark Podesta, Murillo Bellezzo et al. · Physics in Medicine and Biology · 2017 · 37 citations